EUR 257.5
(1.9%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 6.18 Billion EUR | 0.37% |
2022 | 6.1 Billion EUR | 24.55% |
2021 | 4.7 Billion EUR | 72.56% |
2020 | 2.6 Billion EUR | -31.71% |
2019 | 3.81 Billion EUR | 85.63% |
2018 | 2.62 Billion EUR | 2.44% |
2017 | 2.21 Billion EUR | 29.25% |
2016 | 1.71 Billion EUR | 6.27% |
2015 | 1.61 Billion EUR | 21.75% |
2014 | 1.32 Billion EUR | 18.43% |
2013 | 1.11 Billion EUR | 1.55% |
2012 | 1.09 Billion EUR | 20.35% |
2011 | 892.17 Million EUR | 5.28% |
2010 | 831.09 Million EUR | 9.13% |
2009 | 730.14 Million EUR | 14.93% |
2008 | 689.09 Million EUR | 2.43% |
2007 | 673.14 Million EUR | 11.02% |
2006 | 603.65 Million EUR | 12.37% |
2005 | 527.57 Million EUR | -1.86% |
2004 | 461.28 Million EUR | 7.44% |
2003 | 514.17 Million EUR | 2.8% |
2002 | 500.17 Million EUR | 9.54% |
2001 | 456.6 Million EUR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 2.99 Billion EUR | 0.0% |
2023 Q2 | 3.34 Billion EUR | 0.0% |
2023 Q4 | 2.89 Billion EUR | 0.0% |
2023 FY | - EUR | 0.37% |
2022 Q4 | 2.96 Billion EUR | 0.0% |
2022 FY | - EUR | 24.55% |
2022 Q2 | 3.2 Billion EUR | 0.0% |
2021 Q2 | 2.31 Billion EUR | 0.0% |
2021 Q4 | 2.64 Billion EUR | 0.0% |
2021 FY | - EUR | 72.56% |
2020 Q4 | 2.01 Billion EUR | 0.0% |
2020 Q2 | 857 Million EUR | 0.0% |
2020 FY | - EUR | -31.71% |
2019 Q4 | 2.03 Billion EUR | 0.0% |
2019 Q2 | 2.17 Billion EUR | 0.0% |
2019 FY | - EUR | 85.63% |
2018 Q4 | 1.04 Billion EUR | 0.0% |
2018 FY | - EUR | 2.44% |
2018 Q2 | 1.22 Billion EUR | 0.0% |
2017 FY | - EUR | 29.25% |
2017 Q2 | 867 Million EUR | 0.0% |
2017 Q4 | 1.34 Billion EUR | 0.0% |
2016 FY | - EUR | 6.27% |
2016 Q2 | 843 Million EUR | 0.0% |
2016 Q4 | 870 Million EUR | 0.0% |
2015 Q2 | 813 Million EUR | 0.0% |
2015 FY | - EUR | 21.75% |
2015 Q4 | 799 Million EUR | 0.0% |
2014 Q2 | 533 Million EUR | 0.0% |
2014 FY | - EUR | 18.43% |
2014 Q4 | 791 Million EUR | 0.0% |
2013 Q2 | 585 Million EUR | 0.0% |
2013 FY | - EUR | 1.55% |
2013 Q4 | 533 Million EUR | 0.0% |
2012 Q4 | 203.79 Million EUR | 0.0% |
2012 Q2 | 203.79 Million EUR | 0.0% |
2012 Q1 | 203.79 Million EUR | 14.58% |
2012 FY | - EUR | 20.35% |
2012 Q3 | 203.79 Million EUR | 0.0% |
2011 Q2 | 177.87 Million EUR | 0.0% |
2011 Q3 | 177.87 Million EUR | 0.0% |
2011 Q4 | 177.87 Million EUR | 0.0% |
2011 FY | - EUR | 5.28% |
2011 Q1 | 177.87 Million EUR | 9.23% |
2010 Q3 | 162.84 Million EUR | 0.0% |
2010 FY | - EUR | 9.13% |
2010 Q4 | 162.84 Million EUR | 0.0% |
2010 Q2 | 162.84 Million EUR | 0.0% |
2010 Q1 | 162.84 Million EUR | 1.54% |
2009 Q1 | 160.36 Million EUR | 13.28% |
2009 Q2 | 160.36 Million EUR | 0.0% |
2009 Q3 | 160.36 Million EUR | 0.0% |
2009 Q4 | 160.36 Million EUR | 0.0% |
2009 FY | - EUR | 14.93% |
2008 Q3 | 141.56 Million EUR | 0.0% |
2008 Q2 | 141.56 Million EUR | 0.0% |
2008 Q1 | 141.56 Million EUR | 0.65% |
2008 FY | - EUR | 2.43% |
2008 Q4 | 141.56 Million EUR | 0.0% |
2007 FY | - EUR | 11.02% |
2007 Q4 | 140.64 Million EUR | 0.0% |
2007 Q3 | 140.64 Million EUR | 0.0% |
2007 Q2 | 140.64 Million EUR | 0.0% |
2007 Q1 | 140.64 Million EUR | 12.74% |
2006 Q1 | 124.74 Million EUR | 17.31% |
2006 Q4 | 124.74 Million EUR | 0.0% |
2006 Q3 | 124.74 Million EUR | 0.0% |
2006 Q2 | 124.74 Million EUR | 0.0% |
2006 FY | - EUR | 12.37% |
2005 Q4 | 106.34 Million EUR | 0.0% |
2005 Q2 | 106.34 Million EUR | 0.0% |
2005 FY | - EUR | -1.86% |
2005 Q1 | 106.34 Million EUR | 239.17% |
2005 Q3 | 106.34 Million EUR | 0.0% |
2004 FY | - EUR | 7.44% |
2004 Q3 | 31.35 Million EUR | 0.0% |
2004 Q1 | 31.35 Million EUR | -56.85% |
2004 Q2 | 31.35 Million EUR | 0.0% |
2004 Q4 | 31.35 Million EUR | 0.0% |
2003 Q1 | 72.66 Million EUR | 179.3% |
2003 Q4 | 72.66 Million EUR | 0.0% |
2003 FY | - EUR | 2.8% |
2003 Q3 | 72.66 Million EUR | 0.0% |
2003 Q2 | 72.66 Million EUR | 0.0% |
2002 Q3 | 26.01 Million EUR | 0.0% |
2002 FY | - EUR | 9.54% |
2002 Q2 | 26.01 Million EUR | 0.0% |
2002 Q1 | 26.01 Million EUR | -50.87% |
2002 Q4 | 26.01 Million EUR | 0.0% |
2001 FY | - EUR | 0.0% |
2001 Q3 | 52.94 Million EUR | 0.0% |
2001 Q2 | 52.94 Million EUR | 0.0% |
2001 Q1 | 52.94 Million EUR | 0.0% |
2001 Q4 | 52.94 Million EUR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Crossject Société Anonyme | -7.29 Million EUR | 84817.654% |
Safe Orthopaedics SA | -5.62 Million EUR | 110003.983% |
Spineway SA | -4.79 Million EUR | 129112.732% |
Amplitude Surgical SA | 24.72 Million EUR | -24895.956% |
Sartorius Stedim Biotech S.A. | 777.2 Million EUR | -695.291% |
bonyf N.V. | -39.89 Thousand EUR | 15493622.975% |